Logo image of CLWT

EURO TECH HOLDINGS CO LTD (CLWT) Stock Fundamental Analysis

NASDAQ:CLWT - Nasdaq - VGG320301275 - Common Stock - Currency: USD

1.26  +0.01 (+0.8%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CLWT. CLWT was compared to 48 industry peers in the Trading Companies & Distributors industry. CLWT has an excellent financial health rating, but there are some minor concerns on its profitability. CLWT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CLWT was profitable.
Of the past 5 years CLWT 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: CLWT reported negative operating cash flow in multiple years.
CLWT Yearly Net Income VS EBIT VS OCF VS FCFCLWT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

With an excellent Return On Assets value of 10.88%, CLWT belongs to the best of the industry, outperforming 89.58% of the companies in the same industry.
CLWT has a better Return On Equity (14.11%) than 62.50% of its industry peers.
With a Return On Invested Capital value of 0.55%, CLWT is not doing good in the industry: 77.08% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 10.88%
ROE 14.11%
ROIC 0.55%
ROA(3y)4.94%
ROA(5y)3.6%
ROE(3y)7.16%
ROE(5y)5.2%
ROIC(3y)N/A
ROIC(5y)N/A
CLWT Yearly ROA, ROE, ROICCLWT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 12.34%, CLWT belongs to the top of the industry, outperforming 85.42% of the companies in the same industry.
In the last couple of years the Profit Margin of CLWT has grown nicely.
With a Operating Margin value of 0.56%, CLWT is not doing good in the industry: 77.08% of the companies in the same industry are doing better.
CLWT has a Gross Margin of 24.09%. This is in the lower half of the industry: CLWT underperforms 68.75% of its industry peers.
CLWT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.56%
PM (TTM) 12.34%
GM 24.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y20.96%
PM growth 5Y87.67%
GM growth 3Y-7.94%
GM growth 5Y3.18%
CLWT Yearly Profit, Operating, Gross MarginsCLWT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLWT is destroying value.
CLWT has about the same amout of shares outstanding than it did 1 year ago.
CLWT has about the same amout of shares outstanding than it did 5 years ago.
There is no outstanding debt for CLWT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLWT Yearly Shares OutstandingCLWT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
CLWT Yearly Total Debt VS Total AssetsCLWT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 2.85 indicates that CLWT is not a great score, but indicates only limited risk for bankruptcy at the moment.
CLWT's Altman-Z score of 2.85 is in line compared to the rest of the industry. CLWT outperforms 41.67% of its industry peers.
CLWT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.85
ROIC/WACC0.05
WACC10.34%
CLWT Yearly LT Debt VS Equity VS FCFCLWT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 2.20 indicates that CLWT has no problem at all paying its short term obligations.
CLWT has a Current ratio (2.20) which is in line with its industry peers.
CLWT has a Quick Ratio of 2.08. This indicates that CLWT is financially healthy and has no problem in meeting its short term obligations.
CLWT's Quick ratio of 2.08 is fine compared to the rest of the industry. CLWT outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.08
CLWT Yearly Current Assets VS Current LiabilitesCLWT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 600.00% over the past year.
The Earnings Per Share has been growing by 88.82% on average over the past years. This is a very strong growth
CLWT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.59%.
The Revenue has been decreasing by -2.25% on average over the past years.
EPS 1Y (TTM)600%
EPS 3Y33.89%
EPS 5Y88.82%
EPS Q2Q%133.33%
Revenue 1Y (TTM)6.59%
Revenue growth 3Y10.33%
Revenue growth 5Y-2.25%
Sales Q2Q%-8.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLWT Yearly Revenue VS EstimatesCLWT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.50, the valuation of CLWT can be described as very cheap.
CLWT's Price/Earnings ratio is rather cheap when compared to the industry. CLWT is cheaper than 100.00% of the companies in the same industry.
CLWT is valuated cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.5
Fwd PE N/A
CLWT Price Earnings VS Forward Price EarningsCLWT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLWT is valued more expensive than 81.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46.2
CLWT Per share dataCLWT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CLWT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EURO TECH HOLDINGS CO LTD

NASDAQ:CLWT (7/17/2025, 11:41:28 AM)

1.26

+0.01 (+0.8%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-28 2025-04-28
Earnings (Next)12-17 2025-12-17
Inst Owners3.51%
Inst Owner Change0%
Ins Owners2.62%
Ins Owner ChangeN/A
Market Cap9.73M
Analysts0
Price TargetN/A
Short Float %1.58%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.5
Fwd PE N/A
P/S 0.56
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 0.69
EV/EBITDA 46.2
EPS(TTM)0.28
EY22.22%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.23
BVpS1.95
TBVpS1.81
PEG (NY)N/A
PEG (5Y)0.05
Profitability
Industry RankSector Rank
ROA 10.88%
ROE 14.11%
ROCE 0.61%
ROIC 0.55%
ROICexc 0.77%
ROICexgc 0.86%
OM 0.56%
PM (TTM) 12.34%
GM 24.09%
FCFM N/A
ROA(3y)4.94%
ROA(5y)3.6%
ROE(3y)7.16%
ROE(5y)5.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y20.96%
PM growth 5Y87.67%
GM growth 3Y-7.94%
GM growth 5Y3.18%
F-ScoreN/A
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.08
Altman-Z 2.85
F-ScoreN/A
WACC10.34%
ROIC/WACC0.05
Cap/Depr(3y)21.69%
Cap/Depr(5y)23.59%
Cap/Sales(3y)0.03%
Cap/Sales(5y)0.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)600%
EPS 3Y33.89%
EPS 5Y88.82%
EPS Q2Q%133.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.59%
Revenue growth 3Y10.33%
Revenue growth 5Y-2.25%
Sales Q2Q%-8.77%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y193.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.35%
OCF growth 3YN/A
OCF growth 5YN/A